President & Chief Executive Officer, Board Member

Chief Financial Officer

Dianthus enters exclusive license agreement with Leads Biolabs for DNTH212

The biggest biotech funding rounds in September 2025

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2025 AANEM Annual Meeting

Clear Street Initiates Buy on Dianthus Therapeutics, Inc. (DNTH) With $100 Price Target

Senior Director, Regulatory Affairs

Dianthus Therapeutics is developing potentially best in class therapies for patients living with severe autoimmune diseases. The Senior Director of Regulatory Affairs will develop and execute global regulatory strategies, serving as the global regulatory lead for the multifocal motor neuropathy program while ensuring compliance with Health Authority regulations.

Manager, Human Resource Business Partner

SVP, Global Head of Medical Affairs

Chair of the Board of Directors

Sign up with Google

Sign in with Google